CAS: 641571-12-2 - Benzonitrile, 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-
Fórmula:C12H8F3N3
InChI:InChI=1S/C12H8F3N3/c1-8-6-18(7-17-8)11-3-9(5-16)2-10(4-11)12(13,14)15/h2-4,6-7H,1H3
Chave InChI:InChIKey=PTMHYQUJHLKUCC-UHFFFAOYSA-N
SMILES:N#CC=1C=C(C=C(C1)C(F)(F)F)N2C=NC(=C2)C
- Sinónimos:
- 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile
- 3-(4-Methyl-imidazol-1-yl)-5-trifluoromethyl-benzonitrile
- Benzonitrile, 3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-
| Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
|---|---|---|---|---|
 | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile REF: IN-DA00EFU9CAS: 641571-12-2 | 97% | 159,00 €~480,00 € | Ter 07 Jan 25 |
 | Nilotinib Impurity 12 REF: 4Z-N-3116CAS: 641571-12-2 | - - - | A consultar | Ter 07 Jan 25 |
 | 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile REF: 3D-FM96746CAS: 641571-12-2 | Min. 95% | - - - | Produto descontinuado |
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile
CAS:641571-12-2
Fórmula:
C12H8F3N3
Pureza:
97%
Cor e Forma:
Solid
Peso molecular:
251.2072
Ref: IN-DA00EFU9
| 1g | 480,00 € | ||
| 100mg | 159,00 € | ||
| 250mg | 191,00 € |
Entrega estimada em Estados Unidos, Terça-feira 7 de Janeiro de 2025
Nilotinib Impurity 12
CAS:641571-12-2
Fórmula:
C12H8F3N3
Cor e Forma:
White To Off-White Solid
Peso molecular:
251.21
Ref: 4Z-N-3116
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada em Estados Unidos, Terça-feira 7 de Janeiro de 2025
3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile
CAS:641571-12-2
Please enquire for more information about 3-(4-Methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)benzonitrile including the price, delivery time and more detailed …
Fórmula:
C12H8F3N3
Pureza:
Min. 95%
Peso molecular:
251.21 g/mol
Ref: 3D-FM96746
| 5mg | Descontinuado | Solicitar informações | |
| 10mg | Descontinuado | Solicitar informações | |
| 25mg | Descontinuado | Solicitar informações |
